Cambrex ESG Initiatives and Sustainability Practices

This document is a technical report detailing Cambrex's Environmental, Social, and Governance (ESG) initiatives and sustainability practices over the past two decades. It outlines how the pharmaceutical industry has shifted towards integrating ESG programs into core operations, evolving from initial reactions to stakeholder expectations into comprehensive corporate strategies. The report highlights Cambrex's commitment to reducing Scope 1 and Scope 2 greenhouse gas emissions by 20% by the end of 2022 and its efforts to measure Scope 3 emissions as part of its ongoing sustainability strategy. It describes the company's sustainability roadmap, which includes objectives related to ethics, transparency, and responsible corporate citizenship. Additionally, the report mentions Cambrex's collaboration with suppliers to align ESG values and principles, as well as the use of EcoVadis for evaluating supplier performance. The document concludes with a summary of measurable results achieved through these initiatives, including the attainment of significant emissions reduction targets.